ARTICLE | Company News
Allergan, Serenity deal
April 5, 2010 7:00 AM UTC
Serenity granted Allergan exclusive, worldwide rights to develop and commercialize Ser-120 for all indications except primary nocturnal enuresis (pediatric bedwetting). Ser-120, which uses CPE-215 in...